Clinical Trial Update: Efficacy of Short Term Dabigatran Etexilate Followed by Aspirin Monotherapy After LAA (Left Atrial Appendage) Device Closure (the DEA-LAA Study). [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating short-term dabigatran etexilate followed by aspirin monotherapy after left atrial appendage closure with the Watchman d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Left Atrial Appendage Thrombosis

Drugs mentioned

• Dabigatran etexilate (Dabigatran etexilate)

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Atrial Fibrillation, Device Related Thrombus | Phase 4 | Status: COMPLETED | Results posted: 2025-06-10